Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.23% |
| 2 | Technology | 2.7% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Financials | 1.18% |
| 5 | Communication Services | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10876
CALL
VirTra
VTSI
$34.8M
| $103K | ﹤0.01% |
+13,500
| New | +$90.1K |
|
|
ASXC
10877
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
| $103K | ﹤0.01% |
201,300
-31,400
| -13% | -$18.8K |
|
10878
PUT
Amneal Pharmaceuticals
AMRX
$6.27B
| $103K | ﹤0.01% |
33,100
+18,800
| +131% | +$40K |
|
10879
Hydrofarm Holdings
HYFM
$4.29M
| $103K | ﹤0.01% |
13,109
-50,352
| -79% | -$602K |
|
|
STKL
10880
PUT
DELISTED
SunOpta
STKL
| $102K | ﹤0.01% |
15,300
-2,400
| -14% | -$18.1K |
|
|
10881
CALL
Hydrofarm Holdings
HYFM
$4.29M
| $102K | ﹤0.01% |
13,080
-5,840
| -31% | -$69.8K |
|
10882
PUT
Nurix Therapeutics
NRIX
$2.79B
| $102K | ﹤0.01% |
+10,200
| New | +$104K |
|
|
BVC
10883
BitVentures Limited Ordinary Shares
BVC
$2.11B
| $102K | ﹤0.01% |
1,440
-2,794
| -66% | -$178K |
|
10884
Sight Sciences
SGHT
$463M
| $102K | ﹤0.01% |
+12,287
| New | +$111K |
|
10885
PUT
Clene
CLNN
$57.4M
| $101K | ﹤0.01% |
5,750
+970
| +20% | +$18.9K |
|
10886
CALL
Katapult Holdings
KPLT
$480M
| $101K | ﹤0.01% |
4,492
-560
| -11% | -$8.47K |
|
10887
PUT
B2Gold
BTG
$7.7B
| $101K | ﹤0.01% |
28,300
-12,700
| -31% | -$49.7K |
|
10888
Heritage Global
HGBL
$44.3M
| $101K | ﹤0.01% |
+27,895
| New | +$91.9K |
|
10889
Fennec Pharmaceuticals
FENC
$413M
| $101K | ﹤0.01% |
11,429
-149,891
| -93% | -$1.25M |
|
|
AOD
10890
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
| $101K | ﹤0.01% |
+12,217
| New | +$99.4K |
|
|
ATYR
10891
aTyr Pharma
ATYR
$54.4M
| $101K | ﹤0.01% |
+46,634
| New | +$102K |
|
10892
PUT
Angi Inc
ANGI
$189M
| $101K | ﹤0.01% |
3,050
-3,930
| -56% | -$110K |
|
10893
CALL
MiMedx Group
MDXG
$657M
| $100K | ﹤0.01% |
15,200
-1,100
| -7% | -$5.61K |
|
|
CMLS
10894
CALL
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $100K | ﹤0.01% |
+24,500
| New | +$82.3K |
|
|
TESS
10895
DELISTED
Tessco Technologies Inc
TESS
| $100K | ﹤0.01% |
+11,198
| New | +$94.3K |
|
10896
Barnes & Noble Education
BNED
$424M
| $100K | ﹤0.01% |
795
-839
| -51% | -$117K |
|
|
EU
10897
enCore Energy
EU
$270M
| $100K | ﹤0.01% |
+41,556
| New | +$92.8K |
|
10898
PUT
Kodiak Sciences
KOD
$2.46B
| $100K | ﹤0.01% |
+14,500
| New | +$88.7K |
|
|
POL
10899
CALL
DELISTED
Polished.com Inc.
POL
| $99.7K | ﹤0.01% |
4,336
-600
| -12% | -$14.5K |
|
|
RBOT
10900
DELISTED
Vicarious Surgical
RBOT
| $99.5K | ﹤0.01% |
1,812
+655
| +57% | +$41.7K |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.